Examples of 'xiiia' in a sentence
Meaning of "xiiia"
XIIIA is a term that may refer to the protein fibrinogen, specifically the Aalpha chain of the protein
How to use "xiiia" in a sentence
Basic
Advanced
xiiia
Subtype XIIIa has longer blades and hilts.
Fibrin polymers are stabilized by factor XIIIa.
Factor XIIIa is a transglutaminase that is active during coagulation.
Type XIIa has a long grip similar to that of XIIIa.
Factor XIIIa content was measured by means of a fluorometric assay.
Use of the transglutaminase factor XIIIa is specially preferred in the invention.
Factor XIIIa links fibrin polymers that solidify the clot formed.
This was hydrogenated using a platinum catalyst to give XIIa which was hydrolyzed to XIIIa.
Addition of exogenous factor XIIIa was demonstrated to enhance the level of peptide incorporation.
A note about the ability of reptilase to induce factor XIIIa activity seems appropriate.
Factor XIIIa and tissue transglutaminase are up regulated during known physiological conditions.
Fibrin can be crosslinked by Factor XIIIa to from a stabilized clot.
Factor XIIIa then polymerizes the fibrin monomer to form a stabilized fibrin network polymer.
Fibrin can be crosslinked by Factor XIIIa to form a stabilized clot.
Factor XIIIa content of process samples was determined by assaying samples with and without thrombin.
See also
Stocking density is set out in Annex XIIIa by species or group of species.
Which can be produced by use of an optically pure compound of Formula XIIIa.
The active ester XIIIa is then reacted with polypeptide to yield amide bond conjugate XVII.
In a specific embodiment of the invention the transglutaminase is Factor XIIIa of human origin.
Annexes VII and XIIIa are amended in accordance with the Annex to this Regulation.
A compound of formula XII is then cyclized to provide the indenobenzothiophene intermediate of formula XIIIa.
Similarly, ketone XIIIa gives rise to product XIVa.
Thrombin also converts factor XIII into factor XIIIa.
Finally, fibrins are crosslinked by factor XIIIa to produce stable fibrin clot.
In certain embodiments, the subject compounds are of formula XIIIa.
Factor XIIIa is also known as plasma transglutaminase, fibrinoligase or fibrin-stabilising factor.
This bi-domain peptide would contain a factor XIIIa substrate sequence in addition to a heparin-binding sequence.
Factor XIIIa can be added to these samples to promote clot cross-linking.
The peptide chimera consists of two domains, a factor XIIIa substrate and a polysaccharide-binding domain.
Compound XIIIa was also reduced with lithium aluminum hydride to give a mixture of compounds 2 and 3.
This process of cross-linking is catalysed by the enzyme Factor XIIIa.
For example, some factor XIIIa substrates are more efficiently incorporated than others.
The remaining mixture was added to 1 L water with vigorous stirring to precipitate oligomer XIIIa.
In the first design, a factor XIIIa substrate has been directly incorporated onto the protein.
The formulation according to embodiment 6, wherein the transglutaminase domain comprises a Factor XIIIa substrate domain.
Factor XIIIa ( FXIIIa ) covalently bonds these strands to one another to form a rigid mesh.
Compounds of the general formula XIIIa may also be prepared as shown in Scheme 6.
A composition according to any one of claims 7 to 16, further comprising factor XIIIa transglutaminase.
Factor XIIIa content of the dissolved lyophilized material was approximately 0.5 %.
The fibrin chains are cross-linked and stabilized by the plasma factor XIIIa ( FXIIIa ).
Optionally, the kit contains a crosslinking enzyme, such as Factor XIIIa.
Optionally, the kit may contain a crosslinking enzyme, such as Factor XIIIa.
The process according to claim 13, wherein the transglutaminase is Factor XIIIa of human origin.
Specific inhibition has been demonstrated for activated Factors IXa, Xa, XIa, XIIIa and thrombin.
The supplemented matrix according to claim 16, wherein the second domain comprises a Factor XIIIa substrate domain.
Section 7 of Annex XIIIa.
They are identified respectively by immunohistochemical expression of s100, cd1a and factor xiiia.
Other clotting factors include kininogen, kallikrein, and factors VIII, VIIIa, V, Va, XIII, and XIIIa.
